Literature DB >> 26598461

Fluorinated betulinic acid derivatives and evaluation of their anti-HIV activity.

Jizhen Li1, Masuo Goto2, Xiaoming Yang2, Susan L Morris-Natschke2, Li Huang3, Chin-Ho Chen3, Kuo-Hsiung Lee4.   

Abstract

Several fluorinated derivatives of the anti-HIV maturation agent bevirimat (1) were synthesized and evaluated for anti-HIV replication activity. The modified positions were the C-2, C-3, C-28, and C-30 positions, either directly on the betulinic acid (2) skeleton or in the attached side chains. Compound 18, which has a trifluoromethyl group added to C-30 of its isopropenyl group, exhibited similar potency to 1 against HIV-1NL4-3. In total, our current studies support our prior conclusion that C-30 allylic modification is unlikely to be a pharmacophore for anti-HIV activity, but could be a meaningful route to manipulate other properties of 2-related compounds.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-HIV activity; Bevirimat; Fluorinated betulinic acid derivatives

Mesh:

Substances:

Year:  2015        PMID: 26598461      PMCID: PMC4766590          DOI: 10.1016/j.bmcl.2015.11.029

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

1.  Anti-AIDS agents 49. Synthesis, anti-HIV, and anti-fusion activities of IC9564 analogues based on betulinic acid.

Authors:  I-Chen Sun; Chin-Ho Chen; Yoshiki Kashiwada; Jiu-Hong Wu; Hui-Kang Wang; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2002-09-12       Impact factor: 7.446

2.  Anti-AIDS agents 69. Moronic acid and other triterpene derivatives as novel potent anti-HIV agents.

Authors:  Donglei Yu; Yojiro Sakurai; Chin-Ho Chen; Fang-Rong Chang; Li Huang; Yoshiki Kashiwada; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2006-09-07       Impact factor: 7.446

3.  Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents.

Authors:  Y Kashiwada; F Hashimoto; L M Cosentino; C H Chen; P E Garrett; K H Lee
Journal:  J Med Chem       Date:  1996-03-01       Impact factor: 7.446

4.  Anti-AIDS agents 90. novel C-28 modified bevirimat analogues as potent HIV maturation inhibitors.

Authors:  Keduo Qian; Ibrahim D Bori; Chin-Ho Chen; Li Huang; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2012-09-14       Impact factor: 7.446

5.  Betulinic acid derivatives: a new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of action.

Authors:  M Evers; C Poujade; F Soler; Y Ribeill; C James; Y Lelièvre; J C Gueguen; D Reisdorf; I Morize; R Pauwels; E De Clercq; Y Hénin; A Bousseau; J F Mayaux; J B Le Pecq; N Dereu
Journal:  J Med Chem       Date:  1996-03-01       Impact factor: 7.446

6.  Fluorinated natural products: the biosynthesis of fluoroacetate and 4-fluorothreonine in Streptomyces cattleya.

Authors:  Cormac D Murphy; Christoph Schaffrath; David O'Hagan
Journal:  Chemosphere       Date:  2003-07       Impact factor: 7.086

7.  Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents.

Authors:  Keduo Qian; Donglei Yu; Chin-Ho Chen; Li Huang; Susan L Morris-Natschke; Theodore J Nitz; Karl Salzwedel; Mary Reddick; Graham P Allaway; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2009-05-28       Impact factor: 7.446

8.  New betulinic acid derivatives for bevirimat-resistant human immunodeficiency virus type-1.

Authors:  Zhao Dang; Phong Ho; Lei Zhu; Keduo Qian; Kuo-Hsiung Lee; Li Huang; Chin-Ho Chen
Journal:  J Med Chem       Date:  2013-02-20       Impact factor: 7.446

9.  Anti-AIDS agents 81. Design, synthesis, and structure-activity relationship study of betulinic acid and moronic acid derivatives as potent HIV maturation inhibitors.

Authors:  Keduo Qian; Reen-Yun Kuo; Chin-Ho Chen; Li Huang; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

10.  Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors.

Authors:  Zhao Dang; Weihong Lai; Keduo Qian; Phong Ho; Kuo-Hsiung Lee; Chin-Ho Chen; Li Huang
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

View more
  5 in total

Review 1.  Recent advances in natural anti-HIV triterpenoids and analogs.

Authors:  Hai-Feng Wu; Susan L Morris-Natschke; Xu-Dong Xu; Mei-Hua Yang; Yung-Yi Cheng; Shi-Shan Yu; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2020-07-14       Impact factor: 12.944

Review 2.  Plant triterpenoid saponins: biosynthesis, in vitro production, and pharmacological relevance.

Authors:  Tanya Biswas; Upendra N Dwivedi
Journal:  Protoplasma       Date:  2019-07-11       Impact factor: 3.356

Review 3.  Structure and Anti-HIV Activity of Betulinic Acid Analogues.

Authors:  Qiu-Xia Huang; Hong-Fei Chen; Xing-Rui Luo; Yin-Xiang Zhang; Xu Yao; Xing Zheng
Journal:  Curr Med Sci       Date:  2018-06-22

Review 4.  Pentacyclic Triterpene Bioavailability: An Overview of In Vitro and In Vivo Studies.

Authors:  Niege A J C Furtado; Laetitia Pirson; Hélène Edelberg; Lisa M Miranda; Cristina Loira-Pastoriza; Véronique Preat; Yvan Larondelle; Christelle M André
Journal:  Molecules       Date:  2017-03-04       Impact factor: 4.411

5.  Stimulatory Effects of Oleci Acid and Fungal Elicitor on Betulinic Acid Production by Submerged Cultivation of Medicinal Mushroom Inonotus obliquus.

Authors:  Hanghang Lou; Hao Li; Tianyu Wei; Qihe Chen
Journal:  J Fungi (Basel)       Date:  2021-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.